VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 144 filers reported holding VENTYX BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $811,189 | +9.8% | 23,357 | +3.7% | 0.01% | 0.0% |
| Q2 2023 | $738,853 | +83.3% | 22,526 | +87.2% | 0.01% | +66.7% |
| Q1 2023 | $403,173 | +4.2% | 12,035 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $386,758 | +4.2% | 11,795 | +10.8% | 0.00% | 0.0% |
| Q3 2022 | $371,000 | +189.8% | 10,641 | +1.4% | 0.00% | +200.0% |
| Q2 2022 | $128,000 | +82.9% | 10,490 | +102.3% | 0.00% | – |
| Q1 2022 | $70,000 | -36.4% | 5,185 | -6.6% | 0.00% | -100.0% |
| Q4 2021 | $110,000 | – | 5,551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 3,461,536 | $113,503,765 | 35.19% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $24,473,472 | 32.37% |
| Vivo Capital, LLC | 1,303,294 | $42,735 | 4.92% |
| ACUTA CAPITAL PARTNERS, LLC | 290,500 | $7,558,095 | 4.65% |
| TCG Crossover Management, LLC | 787,231 | $25,813,304 | 4.56% |
| Affinity Asset Advisors, LLC | 240,623 | $7,890,028 | 3.09% |
| GREAT POINT PARTNERS LLC | 400,695 | $13,138,789 | 2.58% |
| Logos Global Management LP | 657,016 | $21,543,555 | 2.52% |
| Cormorant Asset Management, LP | 1,080,643 | $35,434 | 2.37% |
| Boxer Capital, LLC | 850,000 | $27,871,500 | 1.47% |